CrossrefInfokarte
Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges
Cancer Treatment Reviews · 2026-11 · 150 · 103203
DOI: 10.1016/j.ctrv.2026.103203 ↗Abstract
Kein Abstract verfügbar.
EUVIMED